Patent · US Active

Antibodies to prostate-specific membrane antigen

USRE43586E1 · kind E1 · reissue

11Cited by
70References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2008
Grant dateAug 14, 2012
Priority date
Expiry dateSep 12, 2028

Classification

  • Technology area (CPC —)General

Abstract

This invention provides purified antibodies to the outer membrane domain of prostate-specific membrane (PSM) antigen, compositions of matter comprising PSM antigen antibodies conjugated to a radioisotope or a toxin, and a method of imaging prostate cancer by using PSM antigen antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.